Stockscreener 앱 받기
69.50
1.74%
1.19
Sol Gel Technologies Ltd 주식(SLGL)의 최신 뉴스
Sol-Gel Technologies: Downgrading To 'Hold' As Success Relies On Upcoming Q4 Catalyst - Seeking Alpha
Bear Alert: Can Falcons Beyond Global Inc deliver consistent dividendsTrade Performance Summary & Fast Momentum Entry Tips - baoquankhu1.vn
Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation - simplywall.st
Value Recap: Is Sol Gel Technologies Ltd. undervalued by DCF analysisQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Inflation Data: Can Sol Gel Technologies Ltd beat the S P 500Weekly Profit Recap & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Declines By 67.2% - MarketBeat
How rising interest rates impact Sol Gel Technologies Ltd. stockJuly 2025 PostEarnings & Low Risk Entry Point Guides - Улправда
Aug Weekly: Will Sol Gel Technologies Ltd. stock gain from lower inflation2025 Top Gainers & Real-Time Chart Pattern Alerts - Улправда
Support Test: How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 WrapUp & Expert-Curated Trade Recommendations - Улправда
Can Sol Gel Technologies Ltd. stock hit record highs againJuly 2025 Reactions & Precise Buy Zone Tips - Улправда
Is Sol Gel Technologies Ltd. stock supported by strong cash flowsJuly 2025 Chart Watch & Consistent Return Investment Signals - ulpravda.ru
How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - ulpravda.ru
Does Sol Gel Technologies Ltd. stock trade at a discount to peersTrade Signal Summary & Short-Term High Return Ideas - Улправда
Can MMP Industries Limited Regain Lost Ground This QuarterStock Liquidity Analysis & Stay Ahead With Daily Market Discussions - bollywoodhelpline.com
Siddhika Coating Limited A Paint CompanyStock Rotation Strategies & Build Diversified Portfolios With Ease - bollywoodhelpline.com
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
FinancialContentRosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - FinancialContent
Opaleye Management Inc. Buys 22,497 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Opaleye Management Inc. Acquires 35,169 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Market Moves: Why Sol Gel Technologies Ltd stock could see breakout soonAnalyst Upgrade & Weekly Top Stock Performers List - Bộ Nội Vụ
Weekly Analysts’ Ratings Changes for Sol-Gel Technologies (SLGL) - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $361,500.30 in Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Purchases 35,169 Shares of Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys $944,649.03 in Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $10,831.60 in Stock - MarketBeat
Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys 1,019 Shares of Stock - MarketBeat
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $67,771.68 in Stock - MarketBeat
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth - Yahoo Finance
Sol-Gel Technologies (SLGL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What is HC Wainwright's Estimate for SLGL FY2025 Earnings? - MarketBeat
What analysts say about Sol Gel Technologies Ltd stockAI-Driven Market Analysis & Small Investment Capital Gains - earlytimes.in
Sol-Gel Technologies’ (SLGL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Receives "Buy" Rating from HC Wainwright - MarketBeat
HC Wainwright & Co. Reiterates Sol-Gel Technologies (SLGL) Buy Recommendation - Nasdaq
SLGL: HC Wainwright & Co. Reiterates Buy Rating with $50 Price T - GuruFocus
What dividend safety score for Sol Gel Technologies Ltd. stockWeekly Market Summary & Free Community Supported Trade Ideas - Улправда
Will Sol Gel Technologies Ltd. stock gain from lower inflationJuly 2025 WrapUp & Community Shared Stock Ideas - Улправда
Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires 2,735 Shares of Stock - MarketBeat
Owner Opaleye Management Inc Buys 2,735 ($110.4K) Of Sol-Gel Technologies Ltd [SLGL] - TradingView — Track All Markets
How analysts rate Sol Gel Technologies Ltd. stock todayJuly 2025 Chart Watch & Fast Entry High Yield Tips - bolumsonucanavari.com
Is Sol Gel Technologies Ltd. stock a buy before product launchesQuarterly Profit Report & Daily Technical Forecast Reports - DonanımHaber
Why Sol Gel Technologies Ltd. stock could see breakout soonMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Sol Gel Technologies Ltd. stock benefit from upcoming earnings reports2025 Valuation Update & Safe Capital Growth Plans - Улправда
Sol-Gel Technologies (SLGL) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Sol-Gel to End SGT-210 Trial in Darier Disease - marketscreener.com
Sol-Gel halts Darier disease treatment after failed clinical trial By Investing.com - Investing.com Nigeria
Why Is Small Cap Sol-Gel Tech Stock Falling Today? - Benzinga
Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results - TipRanks
Sol-Gel Technologies (SLGL) files update on SGT-210 Darier Phase 1b - Stock Titan
Sol-Gel halts studies for rare disease drug (SLGL:NASDAQ) - Seeking Alpha
Sol-Gel Technologies (SLGL) Discontinues SGT-210 Development for Darier Disease - GuruFocus
Sol-Gel halts Darier disease treatment after failed clinical trial - Investing.com
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease - The Manila Times
Rare skin disease trial shows no clear gain, research focus shifts - Stock Titan
Owner Opaleye Management Inc Buys 87 ($3.5K) Of Sol-Gel Technologies Ltd [SLGL] - TradingView — Track All Markets
Sol-Gel Technologies (SLGL) insider files report on new share purchase - Stock Titan
Exit Recap: Will Sol Gel Technologies Ltd stock recover faster than peersQuarterly Market Review & Weekly Setup with ROI Potential - moha.gov.vn
Revenues Not Telling The Story For Sol-Gel Technologies Ltd. (NASDAQ:SLGL) After Shares Rise 30% - Sahm
Owner Opaleye Management Inc Buys 744 ($29.5K) Of Sol-Gel Technologies Ltd [SLGL] - TradingView — Track All Markets
4.73%
0.92%
자본화:
|
볼륨(24시간):